Due to the possible antitumor effect of PCAT19, we screened out six target genes (ADAMTS18, CDH5, EDNRB, PROX1, RASL10A, and SYNM) that were both downregulated in BC and had tumor‐suppressing ability with experimental support22 (Figure 2D). Here, RASL10A is linked to breast cancer.